Swiss National Bank’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.36M Buy
75,600
+12,700
+20% +$922K ﹤0.01% 1214
2025
Q4
$4.75M Buy
62,900
+19,500
+45% +$1.23M ﹤0.01% 1382
2025
Q3
$1.72M Buy
43,400
+800
+2% +$30.5K ﹤0.01% 1925
2025
Q2
$1.85M Sell
42,600
-1,000
-2% -$38K ﹤0.01% 1845
2025
Q1
$1.63M Sell
43,600
-700
-2% -$27.1K ﹤0.01% 1884
2024
Q4
$2.01M Buy
44,300
+6,600
+18% +$337K ﹤0.01% 1851
2024
Q3
$2.21M Sell
37,700
-4,500
-11% -$216K ﹤0.01% 1806
2024
Q2
$1.66M Buy
42,200
+900
+2% +$43.7K ﹤0.01% 1911
2024
Q1
$2.74M Buy
41,300
+8,300
+25% +$362K ﹤0.01% 1661
2023
Q4
$922K Buy
+33,000
New +$662K ﹤0.01% 2283

Other funds holding APGE